Published in J Cell Biol on March 15, 2010
Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov (2010) 7.48
Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol (2010) 7.26
Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med (2011) 4.91
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol (2012) 4.84
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol (2013) 3.39
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev (2012) 3.34
Refilling drug delivery depots through the blood. Proc Natl Acad Sci U S A (2014) 2.10
Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomedicine (2012) 1.94
Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol (2011) 1.90
Programmable probiotics for detection of cancer in urine. Sci Transl Med (2015) 1.73
Etchable plasmonic nanoparticle probes to image and quantify cellular internalization. Nat Mater (2014) 1.72
Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc Natl Acad Sci U S A (2011) 1.68
Receptor-mediated transcytosis: a mechanism for active extravascular transport of nanoparticles in solid tumors. J Control Release (2012) 1.61
Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development. Bioconjug Chem (2015) 1.58
Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett (2014) 1.55
In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. ACS Nano (2012) 1.53
Applications of viral nanoparticles in medicine. Curr Opin Biotechnol (2011) 1.49
Analysis on the current status of targeted drug delivery to tumors. J Control Release (2012) 1.48
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4. Sci Transl Med (2012) 1.42
Peptides as targeting elements and tissue penetration devices for nanoparticles. Adv Mater (2012) 1.41
Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine (2014) 1.34
Nanoparticle-induced vascular blockade in human prostate cancer. Blood (2010) 1.30
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation. Stem Cells Int (2013) 1.30
TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance. J Am Chem Soc (2012) 1.28
M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer. Nat Nanotechnol (2012) 1.27
Tumor vasculature targeting and imaging in living mice with reduced graphene oxide. Biomaterials (2013) 1.26
Cancer treatment using peptides: current therapies and future prospects. J Amino Acids (2012) 1.23
Tropism-modification strategies for targeted gene delivery using adenoviral vectors. Viruses (2010) 1.17
In vivo assembly of nanoparticle components to improve targeted cancer imaging. Proc Natl Acad Sci U S A (2010) 1.15
De novo design of a tumor-penetrating peptide. Cancer Res (2012) 1.12
Advances in the field of nanooncology. BMC Med (2010) 1.11
In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles. Nat Commun (2013) 1.11
M13 phage-functionalized single-walled carbon nanotubes as nanoprobes for second near-infrared window fluorescence imaging of targeted tumors. Nano Lett (2012) 1.11
Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol (2010) 1.11
Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. Nat Biotechnol (2012) 1.10
Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report. Am J Respir Crit Care Med (2010) 1.09
TumorHoPe: a database of tumor homing peptides. PLoS One (2012) 1.07
In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene. Biomaterials (2012) 1.07
Tumor-penetrating peptides. Front Oncol (2013) 1.06
Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer. Front Immunol (2015) 1.06
Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1. Br J Cancer (2014) 1.05
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs. Chem Rev (2016) 1.02
MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent. Nat Commun (2015) 1.01
Synthesis and evaluation of indole-based chalcones as inducers of methuosis, a novel type of nonapoptotic cell death. J Med Chem (2012) 1.01
Cancer-targeted optical imaging with fluorescent zinc oxide nanowires. Nano Lett (2011) 1.00
Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes. Proc Natl Acad Sci U S A (2014) 0.99
Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine. Front Chem (2014) 0.97
Stimuli-responsive nanomaterials for biomedical applications. J Am Chem Soc (2015) 0.97
Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice. Proc Natl Acad Sci U S A (2010) 0.97
Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery. J Transl Med (2012) 0.96
X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew Chem Int Ed Engl (2011) 0.96
Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32. Mol Ther (2013) 0.95
Engineering building blocks for self-assembling protein nanoparticles. Microb Cell Fact (2010) 0.95
Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A (2011) 0.95
Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model. Ann Biomed Eng (2012) 0.95
Empirical chemosensitivity testing in a spheroid model of ovarian cancer using a microfluidics-based multiplex platform. Biomicrofluidics (2013) 0.95
The multicompartmental p32/gClqR as a new target for antibody-based tumor targeting strategies. J Biol Chem (2010) 0.94
Nanotechnology-based approaches in anticancer research. Int J Nanomedicine (2012) 0.93
Polymerization of a peptide-based enzyme substrate. Chem Commun (Camb) (2013) 0.93
Cancer cell invasion: treatment and monitoring opportunities in nanomedicine. Adv Drug Deliv Rev (2011) 0.93
Application of a proapoptotic peptide to intratumorally spreading cancer therapy. Cancer Res (2012) 0.93
Peptide-directed highly selective targeting of pulmonary arterial hypertension. Am J Pathol (2011) 0.93
Computational approach for designing tumor homing peptides. Sci Rep (2013) 0.92
Biocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups. Int J Nanomedicine (2012) 0.92
Cationic liposome-nucleic acid complexes for gene delivery and gene silencing. New J Chem (2014) 0.92
Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales. Br J Pharmacol (2013) 0.92
Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal. Proc Natl Acad Sci U S A (2014) 0.92
Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer. Int J Nanomedicine (2013) 0.91
Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications. Acta Biomater (2014) 0.91
Nanomedicine as an emerging approach against intracellular pathogens. Int J Nanomedicine (2011) 0.91
Effect of magnetic fields on tumor growth and viability. Comp Med (2011) 0.91
Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers. Cancer Lett (2012) 0.90
Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly(ethylene glycol)-poly(ɛ-caprolactone) nanoparticles. Int J Nanomedicine (2012) 0.90
Unexpected multivalent display of proteins by temperature triggered self-assembly of elastin-like polypeptide block copolymers. Biomacromolecules (2012) 0.90
Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies. Proc Natl Acad Sci U S A (2013) 0.90
Optimization of a cyclic peptide inhibitor of Ser/Thr phosphatase PPM1D (Wip1). Biochemistry (2011) 0.89
Gold nanoparticles in radiation research: potential applications for imaging and radiosensitization. Transl Cancer Res (2013) 0.88
Uptake and transfection efficiency of PEGylated cationic liposome-DNA complexes with and without RGD-tagging. Biomaterials (2014) 0.88
Delivery of cancer therapeutics using nanotechnology. Pharmaceutics (2013) 0.88
Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example. BioDrugs (2013) 0.88
Biomaterials and emerging anticancer therapeutics: engineering the microenvironment. Nat Rev Cancer (2015) 0.88
Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels. Neoplasia (2012) 0.86
Multivalent porous silicon nanoparticles enhance the immune activation potency of agonistic CD40 antibody. Adv Mater (2012) 0.85
New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles. PLoS One (2013) 0.85
A tunable coarse-grained model for ligand-receptor interaction. PLoS Comput Biol (2013) 0.85
Nanoparticles: Pushed off target with proteins. Nat Nanotechnol (2013) 0.84
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings. J Control Release (2013) 0.84
Quantity and accessibility for specific targeting of receptors in tumours. Sci Rep (2014) 0.84
Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles. Mol Imaging (2011) 0.84
Biomedical applications of zinc oxide nanomaterials. Curr Mol Med (2013) 0.83
Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy. Cancer Lett (2013) 0.83
Multifunctional hierarchically assembled nanostructures as complex stage-wise dual-delivery systems for coincidental yet differential trafficking of siRNA and paclitaxel. Nano Lett (2013) 0.83
A mathematical model for the rational design of chimeric ligands in selective drug therapies. CPT Pharmacometrics Syst Pharmacol (2013) 0.83
Fluorescence microscopy colocalization of lipid-nucleic acid nanoparticles with wildtype and mutant Rab5-GFP: A platform for investigating early endosomal events. Biochim Biophys Acta (2015) 0.83
Enhanced therapeutic efficacy of iRGD-conjugated crosslinked multilayer liposomes for drug delivery. Biomed Res Int (2013) 0.82
Self-assembled micelles of novel amphiphilic copolymer cholesterol-coupled F68 containing cabazitaxel as a drug delivery system. Int J Nanomedicine (2014) 0.81
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy. J Nanobiotechnology (2016) 0.80
Construction and application of elastin like polypeptide containing IL-4 receptor targeting peptide. PLoS One (2013) 0.80
Peptide-Based Treatment: A Promising Cancer Therapy. J Immunol Res (2015) 0.80
Drug delivery nanoparticles in skin cancers. Biomed Res Int (2014) 0.80
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell (1996) 23.99
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science (2009) 18.40
Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release (2000) 14.89
Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science (1994) 12.83
Renal clearance of quantum dots. Nat Biotechnol (2007) 12.54
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A (2003) 12.17
Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer (2010) 11.16
Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev (2001) 10.02
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science (1998) 8.11
Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell (1989) 7.21
High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer (2004) 5.99
Organ targeting in vivo using phage display peptide libraries. Nature (1996) 5.20
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci U S A (2007) 5.17
Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A (2004) 4.95
Tumor regression by targeted gene delivery to the neovasculature. Science (2002) 4.78
Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater (2009) 4.77
PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol (2005) 4.57
Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem Soc Rev (2006) 4.52
Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today (2006) 4.35
Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell (2009) 4.02
Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med (1998) 3.85
Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med (1999) 3.72
Transport of molecules, particles, and cells in solid tumors. Annu Rev Biomed Eng (1999) 3.64
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol (2007) 3.36
Genes that distinguish physiological and pathological angiogenesis. Cancer Cell (2007) 3.35
Specialization of tumour vasculature. Nat Rev Cancer (2002) 3.30
Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res (2001) 3.29
Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci U S A (2007) 3.26
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res (2000) 3.24
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24
Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell (2002) 3.11
Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat Biotechnol (2003) 3.01
Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol (2001) 2.95
Multivalent effects of RGD peptides obtained by nanoparticle display. J Med Chem (2006) 2.91
A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med (2002) 2.77
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol (2003) 2.68
TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol Med (2007) 2.60
Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science (1997) 2.59
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell (2003) 2.56
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc Natl Acad Sci U S A (2008) 2.55
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience. Blood (2009) 2.54
Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol (2008) 2.49
Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res (2006) 2.46
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci U S A (2009) 2.41
A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo. Proc Natl Acad Sci U S A (2002) 2.35
Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance. Adv Drug Deliv Rev (2008) 2.16
Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small (2009) 2.16
Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res (2008) 2.13
Regulation of extravascular coagulation by microvascular permeability. Science (1985) 2.11
TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI). Cancer Res (2004) 2.07
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell (2003) 2.07
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma. PLoS Med (2008) 2.06
Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci U S A (2002) 2.01
Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci U S A (1999) 1.96
Targeting of albumin-embedded paclitaxel nanoparticles to tumors. Nanomedicine (2008) 1.90
The folate receptor: what does it promise in tissue-targeted therapeutics? Cancer Metastasis Rev (2007) 1.84
Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc Natl Acad Sci U S A (2009) 1.82
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc Natl Acad Sci U S A (2004) 1.82
Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library. J Cell Biol (1994) 1.80
SERS-Coded Gold Nanorods as a Multifunctional Platform for Densely Multiplexed Near-Infrared Imaging and Photothermal Heating. Adv Mater (2009) 1.79
Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res (2002) 1.74
Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed Engl (2008) 1.71
Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proc Natl Acad Sci U S A (2006) 1.68
Is anticancer drug development heading in the right direction? Cancer Res (2009) 1.56
Impaired angiogenesis in aminopeptidase N-null mice. Proc Natl Acad Sci U S A (2007) 1.53
Targeting adenovirus. Gene Ther (2000) 1.49
Perspectives on cancer therapy with radiolabeled monoclonal antibodies. J Nucl Med (2005) 1.49
Fibroblast growth factor-2 binds to the regulatory beta subunit of CK2 and directly stimulates CK2 activity toward nucleolin. J Biol Chem (1996) 1.34
Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo. Nat Biotechnol (2008) 1.33
Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature. PLoS One (2009) 1.33
Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium. J Biol Chem (2000) 1.33
Protease-triggered unveiling of bioactive nanoparticles. Small (2008) 1.30
A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI. Bioconjug Chem (2008) 1.29
Mesoporous silica beads embedded with semiconductor quantum dots and iron oxide nanocrystals: dual-function microcarriers for optical encoding and magnetic separation. Anal Chem (2006) 1.25
An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a "binding site barrier". Cancer Res (1991) 1.23
Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice. Cancer Res (2001) 1.21
Synthesis and characterization of Co/CdSe core/shell nanocomposites: bifunctional magnetic-optical nanocrystals. J Am Chem Soc (2005) 1.21
A role for the NG2 proteoglycan in glioma progression. Cell Adh Migr (2008) 1.20
Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials (2009) 1.19
Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. Cancer Res (2000) 1.13
Coupling tumor necrosis factor-alpha with alphaV integrin ligands improves its antineoplastic activity. Cancer Res (2004) 1.12
The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples. Cancer Res (2009) 1.11
Multicomponent nanoparticles via self-assembly with cross-linked block copolymer surfactants. Langmuir (2007) 1.08
Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy. Radiology (2008) 1.08
Molecular changes in the vasculature of injured tissues. Am J Pathol (2007) 1.08
Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours. Eur J Cancer (2010) 1.08
Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature. Angiogenesis (2009) 1.08
Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors. J Biol Chem (2009) 1.05
Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice. J Clin Invest (2008) 1.02
Inhibition of experimental metastasis by targeting the HUIV26 cryptic epitope in collagen. Am J Pathol (2006) 1.02
Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motif. Cancer Res (2008) 0.97
Collagen targeting using protein-functionalized micelles: the strength of multiple weak interactions. J Am Chem Soc (2009) 0.97
New targeted probes for radioimaging of angiogenesis. Methods (2009) 0.92
Identification of endothelial cell-surface proteins as targets for diagnosis and treatment of disease. Nat Med (1996) 0.91
Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells. PLoS One (2009) 0.90
Visual recognition and efficient isolation of apoptotic cells with fluorescent-magnetic-biotargeting multifunctional nanospheres. Clin Chem (2007) 0.90
Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo. Mol Cancer Res (2009) 0.89
A proteomic approach for the identification of vascular markers of liver metastasis. Cancer Res (2009) 0.87
Two-step radio-immunotargeting of renal-cell carcinoma xenografts in nude mice with anti-renal-cell-carcinoma X anti-DTPA bispecific monoclonal antibodies. Int J Cancer (1998) 0.86
Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A (2002) 5.35
Microscale culture of human liver cells for drug development. Nat Biotechnol (2007) 4.85
Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater (2009) 4.77
An extracellular matrix microarray for probing cellular differentiation. Nat Methods (2005) 4.35
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci U S A (2011) 4.15
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater (2012) 4.10
Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater (2011) 3.83
Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res (2009) 3.77
Micromechanical control of cell-cell interactions. Proc Natl Acad Sci U S A (2007) 3.53
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol (2010) 3.44
Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev (2008) 3.43
Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci U S A (2007) 3.26
Probing the role of multicellular organization in three-dimensional microenvironments. Nat Methods (2006) 3.20
Biomolecular screening with encoded porous-silicon photonic crystals. Nat Mater (2002) 3.13
Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels. FASEB J (2006) 2.95
Biosensing using porous silicon double-layer interferometers: reflective interferometric Fourier transform spectroscopy. J Am Chem Soc (2005) 2.56
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A (2010) 2.44
Targeted quantum dot conjugates for siRNA delivery. Bioconjug Chem (2007) 2.31
Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 2.20
Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small (2009) 2.16
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy. Proc Natl Acad Sci U S A (2012) 2.13
Humanized mice with ectopic artificial liver tissues. Proc Natl Acad Sci U S A (2011) 2.03
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging. Adv Mater (2008) 2.01
In vivo tumor cell targeting with "click" nanoparticles. Bioconjug Chem (2008) 2.01
Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Mol Pharmacol (2010) 1.99
Cancer vulnerabilities unveiled by genomic loss. Cell (2012) 1.95
A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe (2013) 1.95
Delivery of nanogram payloads using magnetic porous silicon microcarriers. Lab Chip (2006) 1.93
Manipulation of liquid droplets using amphiphilic, magnetic one-dimensional photonic crystal chaperones. Nat Mater (2004) 1.89
Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc Natl Acad Sci U S A (2009) 1.82
Engineering the chemistry and nanostructure of porous silicon Fabry-Pérot films for loading and release of a steroid. Langmuir (2004) 1.81
SERS-Coded Gold Nanorods as a Multifunctional Platform for Densely Multiplexed Near-Infrared Imaging and Photothermal Heating. Adv Mater (2009) 1.79
Microfabricated platform for studying stem cell fates. Biotechnol Bioeng (2004) 1.77
Combinatorial signaling microenvironments for studying stem cell fate. Stem Cells Dev (2008) 1.76
Three-dimensional tissue fabrication. Adv Drug Deliv Rev (2004) 1.76
Polymer replicas of photonic porous silicon for sensing and drug delivery applications. Science (2003) 1.72
Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed Engl (2008) 1.71
Porous silicon nanoparticle photosensitizers for singlet oxygen and their phototoxicity against cancer cells. ACS Nano (2011) 1.61
Identification and characterization of receptor-specific peptides for siRNA delivery. ACS Nano (2012) 1.58
Anisotropic stretch-induced hypertrophy in neonatal ventricular myocytes micropatterned on deformable elastomers. Biotechnol Bioeng (2003) 1.58
Formation of steady-state oxygen gradients in vitro: application to liver zonation. Biotechnol Bioeng (2003) 1.58
Single cell trapping and DNA damage analysis using microwell arrays. Proc Natl Acad Sci U S A (2010) 1.53
Engineering protein and cell adhesivity using PEO-terminated triblock polymers. J Biomed Mater Res (2002) 1.50
Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol (2013) 1.49
A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nat Commun (2012) 1.47
Photo- and electropatterning of hydrogel-encapsulated living cell arrays. Lab Chip (2004) 1.46
Oxidation-triggered release of fluorescent molecules or drugs from mesoporous Si microparticles. ACS Nano (2008) 1.44
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells. Hepatology (2011) 1.42
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4. Sci Transl Med (2012) 1.42
Proteolytic actuation of nanoparticle self-assembly. Angew Chem Int Ed Engl (2006) 1.39
Smart dust: self-assembling, self-orienting photonic crystals of porous Si. Proc Natl Acad Sci U S A (2003) 1.39
Tissue-specific gene delivery via nanoparticle coating. Biomaterials (2009) 1.34
Microenvironmental regulation of the sinusoidal endothelial cell phenotype in vitro. Hepatology (2009) 1.33
Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng (2004) 1.32
A biophysical indicator of vaso-occlusive risk in sickle cell disease. Sci Transl Med (2012) 1.32
Porous SiO2 interferometric biosensor for quantitative determination of protein interactions: binding of protein A to immunoglobulins derived from different species. Anal Chem (2007) 1.31
Nanoparticle-induced vascular blockade in human prostate cancer. Blood (2010) 1.30
Protease-triggered unveiling of bioactive nanoparticles. Small (2008) 1.30
Reflective interferometric fourier transform spectroscopy: a self-compensating label-free immunosensor using double-layers of porous SiO2. J Am Chem Soc (2006) 1.27
Quantum dots to monitor RNAi delivery and improve gene silencing. Nucleic Acids Res (2005) 1.26
Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery. Adv Mater (2010) 1.26
Local heating of discrete droplets using magnetic porous silicon-based photonic crystals. J Am Chem Soc (2006) 1.25
In vitro zonation and toxicity in a hepatocyte bioreactor. Toxicol Sci (2004) 1.24
Real-time monitoring of enzyme activity in a mesoporous silicon double layer. Nat Nanotechnol (2009) 1.21
Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells. Proc Natl Acad Sci U S A (2010) 1.20
Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics. Proc Natl Acad Sci U S A (2014) 1.20
Exploring interactions between rat hepatocytes and nonparenchymal cells using gene expression profiling. Hepatology (2004) 1.20
Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials (2009) 1.19
Geometric control of vascular networks to enhance engineered tissue integration and function. Proc Natl Acad Sci U S A (2013) 1.19
Ligand-clustered "patchy" nanoparticles for modulated cellular uptake and in vivo tumor targeting. Angew Chem Int Ed Engl (2010) 1.18
Assessment of hepatocellular function within PEG hydrogels. Biomaterials (2006) 1.18
Mitochondrial localization and the persistent migration of epithelial cancer cells. Biophys J (2013) 1.16
High-throughput analysis of signals regulating stem cell fate and function. Curr Opin Chem Biol (2007) 1.15
Bioresponsive mesoporous silica nanoparticles for triggered drug release. J Am Chem Soc (2011) 1.15
Engineering tissues for in vitro applications. Curr Opin Biotechnol (2006) 1.15
Multiphase electropatterning of cells and biomaterials. Lab Chip (2007) 1.13
Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis. ACS Nano (2013) 1.12
Effect of nanoparticle conjugation on gene silencing by RNA interference. J Am Chem Soc (2010) 1.11
In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles. Nat Commun (2013) 1.11
Nanoparticle self-assembly gated by logical proteolytic triggers. J Am Chem Soc (2007) 1.11
A stable, label-free optical interferometric biosensor based on TiO2 nanotube arrays. ACS Nano (2010) 1.11
Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. Nat Biotechnol (2012) 1.10
A surface-charge study on cellular-uptake behavior of F3-peptide-conjugated iron oxide nanoparticles. Small (2009) 1.07